The global Type 1 Diabetes Market is on track to witness significant expansion over the next decade, driven by rising prevalence rates, advancements in treatment technologies, and a growing understanding of the condition. Valued at USD 32.3 billion in 2023, the market is projected to grow at a compound annual growth rate (CAGR) of 7.82%, reaching USD 63.5 billion by 2032. Get Free Sample Report...